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Predictors of healthy aging have not been well-studied using longitudinal data with demo-
graphic, clinical, subclinical, and genetic information. The objective was to identify predictors





Population-based sample from 6 U.S. communities.
Participants
4,355 participants In the MESA Study.
Measurements
Poor health outcome at 10 years of follow-up was defined as having died or having clinical
cardiovascular disease, depression, cognitive impairment, chronic obstructive pulmonary
disease, or cancer other than non-melanoma skin cancer. Absolute risk regression was
used to estimate risk differences in the outcome adjusting for demographic variables, clinical
and behavioral risk factors, subclinical cardiovascular disease, and ApoE genotype. Models
were weighted to account for selective attrition.
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Results
Mean age at 10 years of follow-up was 69.5 years; 1,480 participants had a poor health out-
come, 2,157 participants were in good health, and 718 were unknown. Older age, smoking,
not taking a statin, hypertension, diabetes, and higher coronary calcium score were associ-
ated with higher probability of poor health outcome. After multivariable adjustment, partici-
pants in the lowest income and educational categories had 7 to 14% greater absolute risk of
poor health outcome at 10 years of follow-up compared to those in the next highest catego-
ries of income or education (P = 0.002 for both). Those in the lowest categories of both
income and education had 21% greater absolute risk of poor health outcome compared to
those in the highest categories of both income and education.
Conclusions
Low income and educational level predict poor health outcome at 10 years of follow-up in an
aging cohort, independent of clinical and behavioral risk factors and subclinical cardiovascu-
lar disease.
Introduction
As life expectancy increases throughout the world, the numbers and proportion of the popula-
tion living to older ages are increasing [1], reflecting both reduction in early life mortality and
improvement in life expectancy for older people [2]. A comparison of two Danish cohorts of
nonegenerians, born in 1905 and 1915 respectively, found that the more recent cohort per-
formed better on tests of physical and cognitive function, suggesting that more people are liv-
ing to older age with better overall function [3]. Others in the field of aging have investigated
the closely related concepts of frailty, functional status, and their correlates [4]. Related work
has focused on multi-morbidity [5] and the burden of disease in the elderly. One challenge in
this field has been the lack of longitudinal data, which are important because of the potential
in retrospective studies for bias arising from recall and from selective cohort truncation to
reach the age of survivorship. A second challenge has been lack of data on a full panoply of
relevant predictors including demographic data, risk factors, measures of subclinical disease,
clinical data, and genetic factors. Recent work by the US Burden of Disease Collaborators
examining years of healthy life lost at the population level confirms the continued importance
of ischemic heart disease and stroke as the first and third leading causes of years of life lost to
premature mortality. Ischemic heart disease is also the leading cause in the U.S. of disability
adjusted life years lost [6]. Thus, cardiovascular risk is of particular importance.
An additional challenge is defining a meaningful endpoint that addresses physical, psycho-
logical, and cognitive health that can be assessed based on objective rather than self-reported
data. We therefore developed a definition of such an endpoint.
The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective, longitudinal study
with detailed characterization of cardiovascular disease risk factors, measures of subclinical
cardiovascular disease together with measures of cognitive function, depression, and other var-
iables of interest including genetic information. We therefore used the rich MESA data set to
examine the extent to which a range of biomedical, behavioral, and social variables including
income and education predict poor health outcome defined to include physical, psychological,
and cognitive health at 10 years of follow-up in a large population-based multi-ethnic cohort.
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Methods
Study Design and Participants
MESA is a longitudinal population-based study of 6,814 men and women aged 45–85 years,
without clinical cardiovascular disease at time of entry, recruited from six U.S. communities
(Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; northern Man-
hattan, NY; and St. Paul, MN). Sampling and recruitment procedures have been reported [7].
The baseline exam was conducted between 8/1/00 and 7/30/02. Follow-up at 10 years (MESA
exam 5) was 76% (n = 4,655) of those alive. Centrally trained and certified study staff per-
formed all participant measurements. The study was approved by the institutional review
boards at all participating centers, specifically the Columbia University Medical Center Institu-
tional Review Board, the Harbor-University of California Los Angeles (UCLA) Research and
Education Institute Human Subjects Committee, the Johns Hopkins University School of
Medicine Joint Committee on Clinical Investigation, the University of Minnesota Human
Research Protection Program, the Northwestern University Social and Behavioral Sciences
Institutional Review Board, the UCLA Office of Human Research Protection Program, the
University of Vermont Committees on Human Research, the Wake Forest University Health
Sciences Office of Research Institutional Review Board, and the University of Washington
Human Subjects Division. All participants gave written informed consent.
Predictor Variables
Questionnaires were used to assess age, gender, race/ethnicity, educational and income levels,
occupational information, smoking status, and medication use for diabetes, lipid lowering,
and hypertension. Classification of race/ethnicity was based on self-identification using ques-
tions based on the U.S. 2000 census questionnaire. Occupation was coded using Census 2000
Occupation Codes and categorized based on NIOSH coding [8]. Health insurance status was
determined by questionnaire and coded as yes or no. Physical activity level was assessed by
questionnaire as previously described9 and minutes of activity were summed for each discrete
activity type and multiplied by metabolic equivalent (MET) level in order to calculate met-
minute/week [9]. Diet was assessed in MESA using a 127-item food frequency questionnaire
based on the food frequency questionnaire that was used in the Insulin Resistance Atheroscle-
rosis Study, which was validated in non-Hispanic white, African American, and Hispanic per-
sons, and further modified to include unique Chinese food and culinary practices [10]. A score
based on ten food components was derived to estimate conformity with the Mediterranean
dietary pattern[11]. Height and weight were measured, and body mass index (BMI) was com-
puted as kg/m2. Blood pressure was measured three times at one minute intervals following a
standardized protocol [12]. The mean of the second and third resting systolic and diastolic
blood pressures was computed. Hypertension was defined as systolic blood pressure140,
diastolic blood pressure90 mmHg, or self-reported high blood pressure and on treatment
with medication for hypertension [13]. Diabetes was defined as being on treatment with insu-
lin or oral medication for diabetes or fasting glucose126 mg/dl [14].
Laboratory Measurements. Fasting blood specimens were analyzed for serum glucose, C-
reactive protein, total cholesterol, high density lipoprotein (HDL) cholesterol, and triglyceride
levels. Low density lipoprotein (LDL) cholesterol was calculated in plasma specimens having a
triglyceride value <400 mg/dL using the Friedewald formula [15]. Apo E4 allele frequency was
determined as previously described [16].
Coronary Artery Calcium Score. Calcified plaque in the coronary arteries was assessed
using computed tomography (CT) following a standardized scanning protocol [17]. Images
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were read [18] and calibrated [19] at the Harbor-UCLA Research and Education Institute
(Torrance, CA). The mean (across two successive scans per participant at the same exam)
Agatston coronary artery calcium (CAC) score was computed [20].
Outcome Variables
Cardiovascular Events. Participants were followed for incident cardiovascular events for
a median of 10.2 years from their baseline examinations. In addition to five follow-up MESA
examinations, a telephone interviewer contacted each participant every 9 to 12 months to
inquire about interim hospital admissions, cardiovascular outpatient diagnoses, and deaths. In
order to verify self-reported diagnoses, copies were requested of all death certificates and med-
ical records for all hospitalizations and outpatient cardiovascular diagnoses. Next of kin inter-
views for out of hospital cardiovascular deaths were obtained [21]. Medical records were
obtained for approximately 99% of reported hospitalized cardiovascular events and informa-
tion on 97% of reported outpatient cardiovascular diagnostic encounters. Follow-up telephone
interviews were completed in 90% of living participants.
Trained personnel abstracted medical records suggesting possible cardiovascular events.
Two physicians independently reviewed all abstracted medical records for endpoint classifica-
tion and assignment of incidence dates, using pre-specified criteria. If the reviewing physicians
disagreed on the event classification, they adjudicated differences. If disagreements persisted,
the full events committee made the final classification. Reviewers classified myocardial infarc-
tion as definite, probable or absent, based primarily on combinations of symptoms (e.g., chest
pain), ECG abnormalities, and cardiac biomarker levels. Coronary heart disease (CHD) death
was classified as present or absent based on hospital records and interviews with families. Defi-
nite fatal CHD required an MI within 28 days of death, chest pain within the 72 hours before
death, or a history of CHD and the absence of a known non-atherosclerotic or non-cardiac
cause of death. Adjudicators determined presence of angina based on documentation of chest
pain or anginal equivalent together with objective evidence of reversible myocardial ischemia
or obstructive coronary artery disease (e.g.,70% coronary artery obstruction or positive
stress test). Coronary artery revascularization was determined from follow-up interviews and
medical records. Stroke required documented focal neurologic deficit lasting 24 hours or until
death, or if < 24 hours, presence of a clinically relevant lesion on brain imaging. Patients with
focal neurologic deficits secondary to brain trauma, tumor, infection, or other non-vascular
cause were excluded. Definite and probable congestive heart failure (CHF) required clinical
symptoms (e.g., shortness of breath) or signs (e.g., edema); asymptomatic disease was not an
endpoint. Probable CHF further required a physician diagnosis of CHF and medical treatment
for CHF. Definite CHF also required pulmonary edema/congestion by chest X-ray and/or
dilated ventricle or poor left ventricular function by echocardiography or ventriculography, or
evidence of left ventricular diastolic dysfunction. Incident peripheral vascular disease was
based on a documented physician diagnosis plus at least one other criteria, namely ultrasound
evidence of obstruction; an exercise test positive for claudication; revascularization for PAD;
amputation for ischemia; ankle-arm ratio0.8; imaging of an aortic aneurysm; or a vascular
procedure for abdominal aortic aneurysm.
Depression and Cognitive Impairment or Dementia
Depression was assessed using the 20 item Centers for Epidemiological Studies Depression
Scale (CES-D) [22] administered at MESA exams 1, 3, 4, and 5. We used the exam 5 CES-D
score as part of the assessment of poor health outcome at exam 5. A score of 16 or greater is
indicative of mild or significant depression [23]. Cognitive function was assessed at exam 5
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only, using the Cognitive Abilities Screening Instrument (CASI) [24]. The CASI assesses per-
formance in multiple domains, including attention, concentration, orientation, short- and
long-term memory, language abilities, visual construction, list generating fluency, abstraction,
and judgment. Individuals with impairment in one domain do not necessarily have impair-
ments in other domains; thus, a specific score may indicate different impairments in different
individuals. It has a range of 0 to 100. We used a cut point of<74 to indicate cognitive
impairment [25]. Dementia was ascertained from ICD-9 codes from hospital records when-
ever a participant was hospitalized and the records were obtained.
Chronic Obstructive Pulmonary Disease (COPD) and non-Melanoma Skin Cancer.
COPD was determined from ICD-9 codes whenever a participant was hospitalized and the
records were obtained. Cancer incidence was based on self-report by participants at telephone
or in person follow-up.
Poor Health Outcome at 10 Years of Follow-up. Poor health outcome at 10 years of fol-
low-up was defined as meeting any of the following criteria at MESA exam 5: (a) occurrence of
death; (b) occurrence of incident CVD (CHD, stroke, congestive heart failure, peripheral vas-
cular disease); (c) presence of depression, defined as score 16 or greater on the CES-D; (d)
presence of cognitive impairment, defined as a score of<74 on the CASI, or of dementia; (e)
presence of chronic obstructive pulmonary disease; and (f) occurrence of cancer other than
non-melanoma skin cancer. The comparison group (“In good health at 10 years of follow-up”)
comprised those alive at exam 5 and having none of the criteria for “poor health outcome”.
Those lost to follow-up, who did not attend Exam 5, or who attended exam 5 but did not com-
plete either the CASI or the CES-D were classified as “Unknown”, unless they had evidence of
a prior event.
Timing of Measurements
All predictor variables were measures at baseline (MESA exam 1). Occurrence of death, inci-
dent CVD, COPD, dementia, and cancer were ascertained continuously over the follow-up
time between MESA exam 1 and exam 5 as described above. Depression and cognitive
impairment were ascertained at MESA exam 5 using questionnaires, as described above.
Statistical Analysis
Characteristics of participants with known health status (either unhealthy or healthy) differed
from those with unknown health status. We therefore used an inverse probability weighting
approach to address this selection bias. For each participant, the probability of having
unknown health status at the follow-up exam was modeled using logistic regression as a func-
tion of the baseline covariates listed in Table 1. Each participant with known health status
(either unhealthy or healthy) was weighted by the inverse of the probability that the participant
was non-missing. Robust standard errors were used to account for the impact of the probabil-
ity weights on the standard errors. Bivariate comparisons and multivariable analysis were per-
formed using the weighted sample. Multivariable absolute risk regression analysis was
performed with all covariates in the model. These models estimate differences in absolute risk
or probability between categories of participants for the outcome of interest. Inclusion of all
relevant covariates in the fully adjusted model did not violate assumptions related to collinear-
ity. Effect modification between income and education was tested by including the interaction
term in the model. The impact of the interaction was illustrated graphically by displaying aver-
age predicted risks at each level of income and education jointly.
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Table 1. Balance of Baseline Characteristics by Unknown Health Status at 10 Years of Follow Up in MESA Before and After Inverse Probability
Weighting (IPW).
Health Status at 10 Years of Follow Up
Before Weighting IPW
Baseline Characteristics Known Unknown p-value Known1 Unknown p-value









Age, y 61.3 (9.9) 62.7 (10.7) 0.001 61.5 (9.9) 61.4 (10.7) 0.774
Male 1916 (52.7) 358 (49.9) 0.167 1897 (52.2) 370 (51.4) 0.716
Race/ethnicity
White 1531 (42.1) 217 (30.2) <0.001 1460 (40.2) 286 (39.7) 0.810
Chinese 466 (12.8) 124 (17.3) 490 (13.5) 91 (12.7)
Black 944 (26.0) 192 (26.7) 951 (26.2) 198 (27.6)
Hispanic 696 (19.1) 185 (25.8) 735 (20.2) 144 (20.0)
Married 2339 (64.3) 442 (61.6) 0.161 2320 (63.8) 452 (62.8) 0.628
Income
<$25K 913 (25.1) 277 (38.6) <0.001 992 (27.3) 194 (26.9) 0.961
$25K-$49K 1046 (28.8) 202 (28.1) 1044 (28.7) 214 (29.8)
$50K-$99K 1091 (30.0) 160 (22.3) 1045 (28.7) 204 (28.3)
$100K+ 587 (16.1) 79 (11.0) 556 (15.3) 108 (15.0)
Education
< High school 488 (13.4) 168 (23.4) <0.001 545 (15.0) 104 (14.5) 0.908
High school 1663 (45.7) 323 (45.0) 1661 (45.7) 339 (47.2)
College 710 (19.5) 125 (17.4) 697 (19.2) 133 (18.6)
Graduate school 776 (21.3) 102 (14.2) 733 (20.2) 142 (19.8)
Occupation
Professional 1711 (47.0) 280 (39.0) 0.002 1661 (45.7) 321 (44.7) 0.887
Service 507 (13.9) 135 (18.8) 533 (14.7) 113 (15.8)
Sales/Office 747 (20.5) 156 (21.7) 746 (20.5) 154 (21.5)
Construction 210 (5.8) 38 (5.3) 213 (5.9) 40 (5.6)
Production 462 (12.7) 109 (15.2) 484 (13.3) 90 (12.5)
Smoking Status
Never 1828 (50.3) 376 (52.4) 0.340 1841 (50.6) 371 (51.5) 0.903
Former 1366 (37.6) 249 (34.7) 1347 (37.0) 260 (36.2)
Current 443 (12.2) 93 (13.0) 448 (12.3) 89 (12.3)
No Health Insurance 247 (6.8) 103 (14.4) <0.001 290 (8.0) 55 (7.7) 0.726
Intentional Exercise
(met-min/week) 1621 (2358) 1658 (2308) 0.699 1630 (2414) 1675 (2182) 0.624
Mediterranean Diet
0–3 1119 (30.8) 232 (32.3) 0.130 1128 (31.0) 226 (31.4) 0.976
4 615 (16.9) 139 (19.4) 629 (17.3) 122 (16.9)
5 693 (19.1) 132 (18.4) 689 (18.9) 139 (19.3)
6 564 (15.5) 113 (15.7) 567 (15.6) 116 (16.1)
7–10 646 (17.8) 102 (14.2) 624 (17.2) 117 (16.2)
BMI 28.1 (5.4) 28.2 (5.5) 0.909 28.1 (5.4) 28.2 (5.3) 0.984
Diabetes 382 (10.5) 87 (12.1) 0.203 391 (10.8) 76 (10.6) 0.917
Hypertension 1533 (42.2) 317 (44.2) 0.322 1545 (42.5) 308 (42.8) 0.884
Hypertension Meds 1290 (35.5) 254 (35.4) 0.962 1289 (35.5) 253 (35.2) 0.915
(Continued )
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Results
Of 6,814 participants at MESA exam 1, 1,353 were excluded because they met criteria for poor
health outcome at Exam 1 and an additional 1,106 were excluded because relevant baseline
data were missing. At exam 5, 1,480 had a poor health outcome, 2,157 were in good health,
and 718 were unknown (Fig 1). The mean age of the cohort was 61.3 years at the baseline
exam and 69.5 years at exam 5. The differences between those with known and unknown
health status at exam 5 were large prior to weighting, with the potential for substantial bias.
After inverse probability weighting, these differences were greatly reduced and all were non-
significant (Table 1).
In bivariate analysis (Table 2), baseline factors that predicted poor health outcome at 10
years of follow up included older age, male sex, black or Hispanic race/ethnicity (with white as
reference group), smoking, presence of diabetes or hypertension, higher systolic and diastolic
blood pressure, higher BMI, lower HDL cholesterol, higher coronary artery calcium score,
higher CRP level, lower family income, lower educational attainment, occupation, and being
unmarried.
In multivariable analysis (Table 3), after adjustment for all predictor variables, those in the
lowest family income group (<$25,000/year) had 7% greater probability of poor health out-
come at 10 years of follow-up compared to those in the next highest income group and 14%
greater probability compared to those in the highest income group. Those in the lowest educa-
tion group (< high school) had 8% greater probability of poor health outcome at 10 years of
follow-up compared to those in the next highest education group, with similar differences
between other education groups. Older age, male gender, current smoking, hypertension, dia-
betes, and higher calcium score were also significantly associated with higher probability of
poor health outcome at 10 years of follow-up. Variables that were not statistically significant
Table 1. (Continued)
Health Status at 10 Years of Follow Up
Before Weighting IPW
Baseline Characteristics Known Unknown p-value Known1 Unknown p-value









Systolic BP, mm Hg 125.1 (20.7) 126.8 (21.2) 0.053 125.4 (20.8) 125.3 (20.2) 0.880
Diastolic BP, mm Hg 72.2 (10.3) 71.9 (9.4) 0.473 72.1 (10.3) 72.1 (9.3) 0.997
Statin Meds 547 (15.0) 99 (13.8) 0.389 538 (14.8) 99 (13.8) 0.529
Total Cholesterol,mg/dL 193.4 (34.3) 194.6 (35.5) 0.389 193.6 (34.5) 193.6 (35.7) 0.984
LDL Cholesterol, mg/dL 117.4 (31.0) 119.0 (32.3) 0.217 117.7 (31.1) 117.8 (32.5) 0.922
HDL Cholesterol, mg/dL 51.0 (14.7) 49.9 (13.9) 0.052 50.8 (14.6) 51.1 (15.1) 0.699
Ln(CRP) 0.6 (1.1) 0.6 (1.2) 0.538 0.6 (1.1) 0.6 (1.2) 0.910
Apo E4
None 2643 (72.7) 537 (74.8) 0.304 2654 (73.0) 523 (72.7) 0.965
Heterozygote 908 (25.0) 161 (22.4) 893 (54.6) 177 (24.7)
Homozygote 86 (2.4) 20 (2.8) 88.9 (2.4) 19 (2.6)
CAC: ln(CAC+1) 2.2 (2.5) 2.2 (2.5) 0.929 2.2 (2.5) 2.2 (2.5) 0.923
1 Note: Known/Unknown sample sizes are the sample sizes after weighting in the IPW columns.
MESA, Multi-Ethnic Study of Atherosclerosis. BMI, body mass index. LDL, low density lipoprotein. HDL, high density lipoprotein. CAC, coronary artery
calcium Agatston score. CRP, C-reactive protein.
doi:10.1371/journal.pone.0165651.t001
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predictors in the fully adjusted model included marital status, no health insurance, physical
activity level, Mediterranean diet score, and body mass index. Compared to those in the lowest
category of both income and education, those at the next highest level of both income and edu-
cation had 7% greater risk, and those at the highest level of both had 21% greater risk, of poor
health outcome at 10 years of follow up. The interaction between family income and educa-
tional level was statistically significant (p< 0.001) (Fig 2), such that the association of educa-
tion with poor health outcome at Exam 5 was stronger at the lowest level of family income
than at higher levels, and vice versa.
There were numerically important contributions from each of the component endpoints to
having a poor health outcome at 10 years of follow-up (Table 4). The associations of lower
family income and lower educational level were statistically significant for all components of
the outcome other than cancer.
Discussion
The main finding of this study is that MESA participants at the lowest income and educational
categories had 7 to14% greater absolute risk of poor health outcome at 10 years of follow-up.
This disadvantage was observed in the lowest income and education groups, namely those
reporting family income less than $25,000 per year in 2000–2002 and those with less than high
Fig 1. Flow chart of participant exclusions from the study. Definition of Poor Health Outcome at MESA
Exam 5: Occurrence of death, cancer (excluding non-melanoma skin cancer),chronic obstructive pulmonary
disease (COPD), cardiovascular disease (CVD; defined as myocardial infarction (MI), cardiac arrest, stroke,
congestive heart failure (CHF), or peripheral vascular disease (PVD), cardiac revascularization, or definite
angina), or presence of cognitive impairment or depression at MESA exam 5. Definition of Healthy: None of
the above diseases/conditions.
doi:10.1371/journal.pone.0165651.g001
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Table 2. Weighted Summary and Bivariate Comparison of Baseline Characteristics by Health Outome Status at 10 Years of Follow Up in MESA.
Baseline Characteristics Poor Health Outcome1 Healthy p-value





Age, y 64.8 (9.8) 59.2 (9.2) <0.001
Male 879 (58.6) 1018 (47.7) <0.001
Race/ethnicity
White 574 (38.3) 886 (41.5) <0.001
Chinese 172 (11.5) 318 (14.9)
Black 417 (27.8) 535 (25.0)
Hispanic 337 (22.4) 398 (18.6)
Married 889 (59.2) 1431 (67.0) <0.001
Income
<$25K 553 (36.8) 439 (20.6) <0.001
$25K-$49K 434 (28.9) 610 (0.29)
$50K-$99K 356 (23.7) 689 (32.3)
$100K+ 158 (10.6) 398 (18.6)
Education
< High school 321 (21.4) 225 (10.5) <0.001
High school 686 (45.7) 975 (45.7)
College 242 (16.1) 456 (21.3)
Graduate school 525 (16.8) 481 (22.5)
Occupation
Professional 601 (40.0) 1060 (49.6) <0.001
Service 262 (17.5) 271 (12.7)
Sales/Office 285 (19.0) 461 (21.6)
Construction 119 (7.9) 94.4 (4.4)
Production 234 (15.6) 250 (11.7)
Smoking Status
Never 685 (45.7) 1156 (54.1) <0.001
Former 583 (38.9) 764 (35.8)
Current 232 (15.5) 216 (10.1)
No Health Insurance 115 (7.7) 175 (8.2) 0.372
Intentional Exercise (met-min/week) 1548 (2314) 1688 (2480) 0.091
Mediterranean Diet
0–3 468 (31.2) 661 (30.9) 0.615
4 276 (18.4) 352 (16.5)
5 279 (18.6) 410 (19.2)
6 227 (15.2) 340 (15.9)
7–10 251 (16.7) 374 (17.5)
BMI 28.6 (5.4) 27.9 (5.4) <0.001
Diabetes 233 (15.5) 158 (7.4) <0.001
Hypertension 774 (51.6) 771 (36.1) <0.001
Hypertension Meds 664 (44.2) 625 (29.3) <0.001
Systolic BP, mm Hg 129.3 (21.6) 122.7 (19.8) <0.001
Diastolic BP, mm Hg 72.7 (10.6) 71.7 (10.1) 0.005
Statin Meds 251 (16.7) 288 (13.5) 0.006
Total Cholesterol, mg/dL 191.8 (33.7) 194.9 (34.9) 0.010
(Continued )
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school education, compared to the next highest income and education groups. There was addi-
tional disadvantage compared to the highest family income group, while the education groups
other than the lowest were similar. Those in the lowest categories of both income and educa-
tion had 21% higher absolute risk of a poor health outcome compared to those in the highest
categories of both income and education. These findings were apparent in bivariate analyses
and also after adjustment for demographic variables, clinical and behavioral risk factors, and
measures of subclinical cardiovascular disease including coronary calcium score. Several other
baseline characteristics, including older age, smoking, hypertension, diabetes, and higher coro-
nary calcium score were also, as expected, associated with greater risk of a poor health outcome
at 10 years of follow-up. The associations of low income and low education with the specific
health outcomes that contributed to poor health outcome at 10 years of follow-up were consis-
tent for each of the components, other than cancer. Of note, with the exception of slightly
lower probability of poor health in Chinese participants, race/ethnicity was not significantly
associated with poor health after other variables were controlled.
Longitudinal studies of older people of necessity need to have been started years ago and
sustained over a long period. Most longitudinal studies have focused on risk factors for specific
diseases, or on functional status, with only a few that have specifically addressed healthy aging.
For example, studies have been done of people who have reached 100 with relative vigor, but
these studies have necessarily had to collect data retrospectively. Some of these studies have
focused on genetic associations, in part as a way to avoid this problem [26]. An exception is
the work of Vaillant et al. [27–29] who studied a cohort of Harvard men recruited in the 1940s
and whose surviving members are still being followed. This work has focused on psychological
adjustment, mental health, and alcoholism. Other relevant work includes that of Newman
et al., who published a comparison of the Long Life Family Cohort (LLFC), who were sampled
conditional in part on living to age 79 or greater in relatively good health, to individuals in
three other cohorts including the Framingham Heart Study, The Cardiovascular Health Study,
and the Framingham Offspring Study [30]. Not surprisingly, the LLFC has lower prevalence of
diabetes, vascular disease, and chronic obstructive pulmonary disease, and higher levels of
measures of functional capacity and performance. Diehr et al. applied a predictive model in
data from the Cardiovascular Health Study to estimate future years of healthy life, where the
Table 2. (Continued)
Baseline Characteristics Poor Health Outcome1 Healthy p-value





LDL Cholesterol, mg/dL 116.7 (30.7) 118.3 (31.3) 0.138
HDL Cholesterol, mg/dL 49.4 (14.2) 51.8 (14.8) <0.001
Ln(CRP) 0.7 (1.1) 0.5 (1.1) <0.001
Apo E4
None 1073 (71.5) 1581 (74.0) 0.143
Heterozygote 384 (25.6) 509 (23.8)
Homozygote 43.4 (2.9) 45 (2.1)
Agatston CAC: ln(CAC+1) 3.0 (2.7) 1.6 (2.2) <0.001
1 Note: Poor Health Outcome/Healthy sample sizes are the sample sizes after weighting. Sample sizes may not add up to column totals due to rounding.
MESA, Multi-Ethnic Study of Atherosclerosis; BMI, body mass index. LDL, low density lipoprotein. HDL, high density lipoprotein. CAC, coronary artery
calcium Agatston score. CRP, C-reactive protein.
doi:10.1371/journal.pone.0165651.t002
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Table 3. Weighted Multivariable Absolute Risk Regression for Poor Health Outcome At 10 Years of
Follow Up in MESA.
Probability of Poor Health Outcome
Model Terms1 (N = 3637) β [95% CI] p-value
Age2 0.09 [0.07,0.11] <0.001
Gender
Female ref
Male 0.07 [0.04,0.11] <0.001
Race/ethnicity
White ref
Chinese -0.06 [-0.11,-0.00] 0.034
Black -0.03 [-0.07,0.01] 0.129
Hispanic -0.04 [-0.09,0.01] 0.111
Married -0.02 [-0.06,0.01] 0.246
Income
<$25K ref
$25K-$49K -0.07 [-0.12,-0.03] 0.002
$50K-$99K -0.11 [-0.16,-0.06] <0.001
$100K+ -0.14 [-0.20,-0.07] <0.001
Education
< High school ref
High school -0.08 [-0.14,-0.03] 0.002
College -0.09 [-0.15,-0.02] 0.007
Graduate school -0.08 [-0.15,-0.02] 0.015
Occupation
Professional ref
Service 0.05 [-0.01,0.10] 0.092
Sales/Office -0.01 [-0.06,0.03] 0.516
Construction 0.07 [-0.00,0.15] 0.056
Production 0.004 [-0.05,0.06] 0.980
Smoking Status
Never ref
Former 0.01 [-0.02,0.04] 0.550
Current 0.14 [0.09,0.19] <0.001
No Health Insurance -0.004 [-0.07,0.06] 0.915
Intentional Exercise, met-min/week -0.01 [-0.03,0.00] 0.073
Mediterranean Diet
0–3 ref
4 -0.005 [-0.05,0.04] 0.834
5 -0.01 [-0.05,0.04] 0.798
6 -0.01 [-0.06,0.04] 0.734
7–10 -0.004 [-0.05,0.04] 0.856
BMI 0.02 [-0.00,0.04] 0.076
Diabetes 0.09 [0.03,0.14] 0.001
Hypertension Meds 0.06 [0.02,0.09] 0.001
Systolic BP, mm Hg 0.01 [-0.01,0.03] 0.301
Statin Meds -0.04 [-0.08,0.01] 0.094
Total Cholesterol, mg/dL -0.01 [-0.03,0.00] 0.068
HDL Cholesterol, mg/dL -0.01 [-0.02,0.01] 0.435
(Continued )
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definition of healthy life was based on the response to the question “Is your health excellent,
very good, good, fair, or poor?” [31] but these authors did not test specific risk factors or ana-
lyze an objective measure of the outcome. The American Heart Association, as part of its effort
to promote cardiovascular health, issued a report on behalf of its Strategic Planning Task
Force and Statistics Committee in which it defined the concept of cardiovascular health (or
ideal cardiovascular health) as presence of four favorable health behaviors (nonsmoking, body
mass index <25 kg/m2, physical activity at goal level, diet consistent with guidelines), presence
of four favorable health factors (abstinence from smoking within the last year, untreated total
cholesterol <200 mg/dl, untreated blood pressure <120/80 mmHg, fasting blood glucose
<100 mg/dl), and absence of clinical CVD [32]. However, other than absence of CVD, these
are risk factors, not states of health or well-being. The Cardiovascular Health Study (CHS) All
Stars Study conducted an examination in 2005–06 of CHS participants aged 77 years and older
Table 3. (Continued)
Probability of Poor Health Outcome
Model Terms1 (N = 3637) β [95% CI] p-value




Homozygote 0.10 [0.00,0.20] 0.048
Agatston CAC: ln(CAC+1) 0.06 [0.04,0.08] <0.001
1 All variables included from Table 1 other than hypertension and LDL Cholesterol; hypertension was omitted
because both systolic blood pressure level and use of anti-hypertensive medications were included in the
model. LDL was omitted because total and HDL cholesterol were included in the model.
2 Continuous variable estimates are per standard deviation.
MESA, Multi-Ethnic Study of Atherosclerosis. BMI, body mass index. HDL, high density lipoprotein. CAC,
coronary artery calcium Agatston score. CRP, C-reactive protein.
doi:10.1371/journal.pone.0165651.t003
Fig 2. Joint probabilities (vertical axis) of poor health outcome at 10 years of follow up in MESA by
income (family income per year) and education level.
doi:10.1371/journal.pone.0165651.g002
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that included measure of cognitive and physical function [33]. Several publications from CHS
All Stars are relevant [34,35,36,37,38,39,40] but none specifically addressed the predictors of
reaching older age in good physical, cognitive, and psychological health.
Our findings were inconsistent with respect to whether there is a gradient across categories
of income and education, depending on the socioeconomic measure. We found such a gradi-
ent for family income but not for educational attainment (Table 3). This pattern may be con-
trasted with the graded association with civil service class and health outcomes seen in the
Whitehall Study [41]. This difference may reflect the different social circumstances in the U.S.
compared to Great Britain as well as the fully employed, working age sample in the Whitehall
Study, which differs from MESA. We did find statistically significant evidence of an interaction
between income and educational level in our data (Fig 2). The interaction observed suggests a
synergistic effect of lower income and lower education (adverse effect of low income is potenti-
ated by low education and vice versa).
We considered several factors that could potentially have contributed to the associations we
observed between low income and education levels with poor health outcome at 10 years of
follow-up. One such factor is lack of access to regular health care, however lack of health
Table 4. Weighted Summary of Baseline Characteristics by Event for Participants with Poor Health Outcome at 10 Years of Follow Up in MESA.
Baseline Characteristics Unhealthy1 Death CVD2 Depression Cognitive
Impairment
COPD Cancer
N = 1480 N = 379 N = 495 N = 329 N = 265 N = 93 N = 499
N (row %) N (row %) N (row %) N (row %) N (row %) N (row %) N (row %)
Female 621 (35.7)† 140 (8.1)† 171 (9.8)† 161 (9.3) 129 (7.4) 37 (2.2) 175 (10.1)†
Male 879 (46.3) 239 (12.6) 324 (17.1) 168 (8.9) 136 (7.2) 55 (2.9) 303 (16.0)
Race/ethnicity
White 574 (39.3)† 137 (9.4)† 209 (14.3)† 129 (8.8) 53 (3.6)† 31 (2.2) 219 (15.0)†
Chinese 172 (35.2) 40 (8.1) 47 (9.6) 44 (8.9) 28 (5.7) 13 (2.7) 39 (7.9)
Black 417 (43.8) 126 (13.3) 125 (13.2) 75 (7.8) 72 (7.6) 34 (3.6) 150 (15.8)
Hispanic 337 (45.8) 76 (10.3) 114 (15.5) 83 (11.3) 112 (15.2) 14 (1.9) 71 (9.6)
Income
<$25K 553 (55.7)† 179 (18.1)† 170 (17.1)† 104 (10.5)† 149 (15.0)† 48 (4.8)† 142 (14.3)
$25K-$49K 434 (41.5) 95 (9.1) 164 (15.7) 106 (10.2) 73 (7.0) 19 (1.8) 126 (12.1)
$50K-$99K 356 (34.0) 79 (7.6) 110 (10.6) 80 (7.7) 39 (3.7) 21 (2.1) 144 (13.8)
$100K+ 158 (28.5) 25 (4.6) 51 (9.1) 40 (7.2) 5 (0.9) 5 (0.8) 66 (11.9)
Education
< High school 320 (58.8)† 82 (15.1)† 98 (18.0)† 67 (12.2) † 112 (20.5)† 24 (4.5)† 71 (13.1)
High school 686 (41.3) 183 (11.0) 232 (14.0) 147 (8.9) 111 (6.7) 43 (2.6) 211 (12.7)
College 242 (34.7) 62 (9.0) 79 (11.3) 57 (8.2) 25 (3.5) 14 (2.0) 90 (12.9)
Graduate school 252 (34.4) 52 (7.0) 86 (11.7) 58 (7.9) 18 (2.5) 12 (1.6) 107 (14.6)
Smoking Status
Never 685 (37.2)† 155 (8.4)† 204 (11.1)† 153 (8.3)† 163 (9.0)† 17 (1.0)† 199 (10.8)†
Former 583 (43.3) 155 (11.5) 203 (15.1) 121 (9.0) 77 (5.7) 43 (3.2) 212 (15.7)
Current 232 (51.9) 69 (15.4) 87 (19.5) 55 (12.2) 25 (5.5) 32 (7.1) 67 (15.1)
1 Notes: Sample sizes are the sample sizes after weighting. Sample sizes may not add up to column totals due to rounding. Row total is less than sum of
numbers in row because some participants had more than one condition as of exam 5.
2 MESA, Multi-Ethnic Study of Atherosclerosis.
CVD Endpoint: MI, cardiac arrest, stroke, CHF, PVD, revascularization, definite angina.
† Statistically significant at p = 0.05.
doi:10.1371/journal.pone.0165651.t004
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insurance was not a significant predictor of the outcome in either bivariate or fully adjusted
analyses. We also considered physical activity level and diet, but these variables also were not
significant in either bivariate or fully adjusted analyses. Chetty et al. recently reported an asso-
ciation between higher income and greater life expectancy in the U.S. [42] Similar to our find-
ings, Chetty et al. did not find that access to health care correlated with the outcome. Other
potential explanatory variables examined by Chetty et al. included local labor markets, residen-
tial segregation, and adverse effects of inequality as measured by the Gini index, but their anal-
yses did not find support for any of these [42] These investigators inferred that most of the
variation in life expectancy was explained by differences in smoking, physical activity, and obe-
sity, however we adjusted for all of these variables and still found important differences by
income and education level in the probability of poor health outcome at 10 years of follow-up
in MESA. Other work in this area has explored the roles of stress and allostatic load [43,44]
and of social context [45,46], which includes physical, psychological, and social aspects of the
environment, as potential factors mediating the relationship between socioeconomic status
and health outcomes.
Several limitations are noted. First, the use of a composite endpoint has potential draw-
backs, in that subjects can attain or fail to attain the endpoint through multiple pathways. This
non-specificity is potentially offset by the clinical and psychological salience of an endpoint
that broadly indexes healthy aging. Non-composite endpoints may also occur through multiple
pathways. This endpoint is innovative in that is derived from the data available in MESA as a
best definition of overall health, but to our knowledge there are no prior publications using
this outcome definition. Secondly, the use of the CASI to define cognitive impairment is not
fully defined based on prior literature. In addition, the CASI was not administered at all
exams. Third, the cancer component of the outcome was based on self-report. Fourth, we used
family income rather than wealth to classify socioeconomic disadvantage. However, the classi-
fication of individuals to income groups used in our analysis is unlikely to change substantially
based on income and wealth data combined. Strengths include the longitudinal design of the
study, the high rate of follow-up, the multi-ethnic and population-based sample, the uniquely
well characterized cardiovascular risk factors and subclinical cardiovascular disease measures
in MESA, use of standardized measures of cognitive function and depression, availability of
Apo E genetic data, and ascertainment of both cardiovascular and non-cardiovascular disease
endpoints.
It might be argued that diabetes should be included in the criteria for poor health outcome,
whereas we included diabetes mellitus among the predictors of poor health outcome at 10
years of follow-up. We did so because not including diabetes in the set of predictors or covari-
ates would have increased the potential for confounding. We also note that for cardiovascular
risk factors, diabetes has traditionally been considered as a predictor [47]. Diabetes is also a
predictor of depression [48] and cognitive impairment [49,50]. We acknowledge that the pres-
ence of diabetes may be considered by some to be a poor health outcome.
In summary, we found that lower family income and lower educational attainment inde-
pendently predict poor health outcome at 10 years of follow-up in the MESA study. These dif-
ferences were of substantial magnitude, ranging from 7 to 14% in absolute risk difference
compared to the next highest categories of income and education, and 21% difference in risk
for those in the lowest categories of both family income and education compared to those in
the highest categories of both. These findings illustrate the impact of low income and educa-
tion level on failing to remain in good health at older age. The unfavorable impact included
adjustment for clinical factors and was observed across a range of components of the poor
health metric, suggesting that clinically targeted interventions alone may not be sufficient to
address preventable and costly loss of health in the aging population.
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